Plain-English translation of NCT07476118 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a medication called in healthy adults with overweight or obesity. Researchers want to understand how the medication works in the body, whether it's safe, and how well it's tolerated at different dose levels. You would receive injections under the skin over about 42 weeks, and researchers would monitor your health closely.
This medication is being developed to help people manage their weight, but researchers first need to test it in healthy people to make sure it's safe before testing it more broadly in patients. This early-stage study helps establish the right doses and identify any side effects.
You will visit the research clinic multiple times over about 42 weeks. During the study, you'll receive injections under your skin — either the new medication or a placebo (a dummy injection with no active ingredient). You won't know which you're receiving. Researchers will do blood tests, check your vital signs, and ask about any side effects or changes you notice. The study is designed to be safe and closely monitored.
AI-generated summary from trial data · Aug 7, 2026 · Not medical advice
United States